Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind Placebo-Controlled Clinical Effectiveness Trial of the 23-Valent Pneumococcal Vaccine Among Military Trainees At Increased Risk of Respiratory Disease

NCT02079701 is registered in ClinicalTrials.gov with Naval Health Research Center as lead sponsor.

NCT NCT02079701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02079701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind Placebo-Controlled Clinical Effectiveness Trial of the 23-Valent Pneumococcal Vaccine Among Military Trainees At Increased Risk of Respiratory Disease
Lead sponsor
Naval Health Research Center
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2000
Completion date
June 30, 2007
Enrollment
152,723 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory disease, pneumonia